5 Best U.S. Regions for Life Science Jobs
3 Biotechs With the Biggest and Most Promising Pipelines
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos
Bristol-Myers Squibb (BMY) May Be on the Market, But Pfizer (PFE) Probably Won't Bite
First Ariad (ARIA), Now Senator Bernie Sanders Puts This Drug Company on Notice
Questions Remain Over Suicide Death of Genentech (RHHBY) Lobbyist
This is Why the Decision on Who Invented CRISPR Matters
How to Write the Best Cover Letter for a Research Scientist Job
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa
Bristol-Myers Squibb (BMY) Could Finally Go on the Market; Rumored Suitors Include Gilead (GILD), Pfizer (PFE), Novartis AG (NVS) and Roche (RHHBY)
Bay Area Biotech Surrozen Launches With $33 Million and Could Double Its Headcount by Next Year
Alexion (ALXN) Stops Work on Early-Stage Sanfilippo B Drug, Takes a $85 Million Write Off
Why Secretive $5 Billion Biotech Moderna May Not be Able to Commercialize Products Into Clinical Trials
With Ex-Juno (JUNO) Employees on Its Roster, Seattle's Silverback Therapeutics Files $10 Million Out of $60 Million Goal
Bay Area Biotech Ardelyx (ARDX) Rejoices as Lead Drug Hits Phase III Goals
New SoCal Biotech Jecure Therapeutics Makes Debut and Will Take on NASH
With All Due Respect President Trump, Drug Companies Don't Want a Deregulated FDA
See All News >